Aurora Cannabis (ACB) Liabilities and Shareholders Equity (2018 - 2025)
Aurora Cannabis (ACB) reported Liabilities and Shareholders Equity of $556.0 million for Q4 2025, down 10.37% year-over-year from $620.3 million in Q4 2024, and up 1.09% quarter-over-quarter from $550.0 million in Q3 2025.
Aurora Cannabis (ACB) Liabilities and Shareholders Equity (2018 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $556.0 million in Q4 2025.
- Liabilities and Shareholders Equity for Q4 2025 came in at $556.0 million, down 10.37% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.3 billion (down 5.88% YoY), and the FY2025 annual result was $594.2 million, down 4.52% from the prior year.
- Liabilities and Shareholders Equity rose to $556.0 million in Q4 2025 per ACB's latest filing, from $550.0 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $2.8 billion in Q3 2021 and troughed at $550.0 million in Q3 2025.
- A 5-year average of $1.0 billion and a median of $621.3 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2021 and 2022: Liabilities and Shareholders Equity rose 5.57% in 2021, then tumbled 68.4% in 2022.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.0 billion in 2021, then sank by 61.75% to $754.3 million in 2022, then dropped by 20.42% to $600.2 million in 2023, then rose by 3.34% to $620.3 million in 2024, then retreated by 10.37% to $556.0 million in 2025.
- Business Quant data shows ACB's Liabilities and Shareholders Equity at $556.0 million in Q4 2025, $550.0 million in Q3 2025, and $604.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 40.04 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 15.15 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.71 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 555.95 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 4.91 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 13.22 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.26 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.35 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 2.27 Bn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 401.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 555.95 Mn |
| Sep 30, 2025 | 549.96 Mn |
| Jun 30, 2025 | 604.68 Mn |
| Mar 31, 2025 | 594.24 Mn |
| Dec 31, 2024 | 620.30 Mn |
| Sep 30, 2024 | 592.87 Mn |
| Jun 30, 2024 | 613.20 Mn |
| Mar 31, 2024 | 622.39 Mn |
| Dec 31, 2023 | 600.24 Mn |
| Sep 30, 2023 | 610.45 Mn |
| Jun 30, 2023 | 619.52 Mn |
| Mar 31, 2023 | 685.20 Mn |
| Dec 31, 2022 | 754.26 Mn |
| Sep 30, 2022 | 897.04 Mn |
| Jun 30, 2022 | 850.50 Mn |
| Mar 31, 2022 | 1.24 Bn |
| Dec 31, 2021 | 1.97 Bn |
| Sep 30, 2021 | 2.84 Bn |
| Jun 30, 2021 | 2.12 Bn |
| Mar 31, 2021 | 2.24 Bn |